Yu-En Tien

Yu-En Tien is a prominent inventor based in Taipei, Taiwan, known for his significant contributions to pharmaceutical advancements. With a total of three patents to his name, Tien has focused on enhancing drug formulations to improve patient care and treatment efficacy.

Latest Patents

Tien's most recent patents involve groundbreaking pharmaceutical formulations for the sustained release of sebacoyl dinalbuphine ester. These inventions relate to injectable, extended-release formulations that include a nalbuphine ester prodrug homogeneously dissolved in a solution of pharmaceutically acceptable oil and an oil-miscible retaining solvent. The patents also detail the manufacturing processes and medical applications of these formulations, providing methods to adjust the duration of their action by varying the proportions of the oil and solvent. This represents a significant advancement in the field of drug delivery systems.

Career Highlights

Yu-En Tien has been instrumental in the development of innovative therapeutic solutions. His professional background includes working with Lumosa Therapeutics Co., Ltd and Shanghai Lumosa Therapeutics Co., Ltd, where he has contributed to developing and refining pharmaceutical products aimed at enhancing patient outcomes.

Collaborations

Throughout his career, Tien has collaborated with notable researchers such as Chan-Jung Li and David Chih-Kuang Chou. These partnerships have further enriched his research and development efforts, leading to innovative breakthroughs in pharmaceutical formulations.

Conclusion

Yu-En Tien's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents not only demonstrate his expertise and commitment to advancing drug delivery methods but also highlight the collaborative nature of scientific research. As he continues to innovate, Tien is poised to make a lasting impact on the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.